Korea Investment Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,060
| Closed | -$989K | – | 703 |
|
|
2025
Q1 | $989K | Buy |
4,060
+100
| +3% | +$24.4K | ﹤0.01% | 699 |
|
|
2024
Q4 | $1.3M | Sell |
3,960
-100
| -2% | -$32.9K | ﹤0.01% | 706 |
|
|
2024
Q3 | $1.36M | Sell |
4,060
-3,600
| -47% | -$1.2M | ﹤0.01% | 708 |
|
|
2024
Q2 | $2.09M | Sell |
7,660
-5,023
| -40% | -$1.37M | 0.01% | 681 |
|
|
2024
Q1 | $4.39M | Sell |
12,683
-567
| -4% | -$196K | 0.01% | 603 |
|
|
2023
Q4 | $4.28M | Buy |
13,250
+1,616
| +14% | +$522K | 0.01% | 609 |
|
|
2023
Q3 | $4.17M | Buy |
11,634
+3,350
| +40% | +$1.2M | 0.01% | 534 |
|
|
2023
Q2 | $3.14M | Sell |
8,284
-1,033
| -11% | -$392K | 0.01% | 598 |
|
|
2023
Q1 | $4.46M | Sell |
9,317
-608
| -6% | -$291K | 0.01% | 551 |
|
|
2022
Q4 | $4.17M | Sell |
9,925
-1,399
| -12% | -$588K | 0.01% | 582 |
|
|
2022
Q3 | $4.72M | Sell |
11,324
-5,291
| -32% | -$2.21M | 0.01% | 562 |
|
|
2022
Q2 | $8.22M | Buy |
16,615
+4,915
| +42% | +$2.43M | 0.03% | 465 |
|
|
2022
Q1 | $6.59M | Buy |
11,700
+1,600
| +16% | +$901K | 0.02% | 526 |
|
|
2021
Q4 | $7.63M | Buy |
10,100
+4,500
| +80% | +$3.4M | 0.02% | 441 |
|
|
2021
Q3 | $4.18M | Sell |
5,600
-100
| -2% | -$74.6K | 0.01% | 547 |
|
|
2021
Q2 | $3.67M | Hold |
5,700
| – | – | 0.01% | 598 |
|
|
2021
Q1 | $3.26M | Sell |
5,700
-600
| -10% | -$343K | 0.01% | 595 |
|
|
2020
Q4 | $3.67M | Buy |
6,300
+400
| +7% | +$233K | 0.01% | 570 |
|
|
2020
Q3 | $3.04M | Buy |
5,900
+200
| +4% | +$103K | 0.01% | 528 |
|
|
2020
Q2 | $2.57M | Buy |
5,700
+200
| +4% | +$90.3K | 0.01% | 554 |
|
|
2020
Q1 | $1.93M | Buy |
+5,500
| New | +$1.93M | 0.01% | 570 |
|